Tag: Viking

Viking Therapeutics Initiates Pivotal Phase 3 Trial: Here’s Why Investors Have Reason for Optimism After a Disappointing Phase 2

Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It’s Not Too Late to Buy the Stock.

How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030?

Don’t Buy Viking Therapeutics Stock Until You Read This

Got $5,000? Viking Therapeutics Might Be a Weight‑Loss Drug Moon Shot in the Making.

Why Viking Therapeutics Stock Popped Nearly 4% Today

Where Will Viking Therapeutics Be in 3 Years?

Prediction: Pfizer’s Loss May Be Viking Therapeutics’ Gain

Will Viking Holdings Cruise Ahead in a Thriving Market?

Here’s Yet Another Reason to Buy Viking Therapeutics Stock Like There’s No Tomorrow